0001493152-24-028205.txt : 20240717
0001493152-24-028205.hdr.sgml : 20240717
20240717171012
ACCESSION NUMBER: 0001493152-24-028205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tenjarla Srini
CENTRAL INDEX KEY: 0002029985
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 241122922
MAIL ADDRESS:
STREET 1: 601 GENOME WAY SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Serina Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821436829
STATE OF INCORPORATION: AL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
BUSINESS PHONE: (256) 327-9630
MAIL ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
FORMER COMPANY:
FORMER CONFORMED NAME: AgeX Therapeutics, Inc.
DATE OF NAME CHANGE: 20170606
4
1
ownership.xml
X0508
4
2024-07-15
0
0001708599
Serina Therapeutics, Inc.
SER
0002029985
Tenjarla Srini
601 GENOME WAY, SUITE 2001
HUNTSVILLE
AL
35806
0
1
0
0
SVP, CMC & Formulation
0
Stock Option (right to buy)
9.50
2024-07-15
4
A
0
185000
0
A
2034-07-15
Common Stock
185000
185000
D
The stock options vest as to 61,666 of the underlying shares on July 15, 2025, and thereafter in substantially equal installments such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
/s/ Srini Tenjarla
2024-07-17